Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

G. Liposits; J. Ryg; H. Skuladottir; S. B. Winther; S. Möller; E. Hofsli; C-H. Shah; L. Poulsen Oestergaard; A. Berglund; C. Qvortrup; P. J. Osterlund; B. Glimelius; H. Sorbye; P. Pfeiffer

doi:10.1016/j.annonc.2022.07.548

Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

G. Liposits, J. Ryg, H. Skuladottir, S. B. Winther, S. Möller, E. Hofsli, C-H. Shah, L. Poulsen Oestergaard, A. Berglund, C. Qvortrup, P. J. Osterlund, B. Glimelius, H. Sorbye, P. Pfeiffer

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	410P
Journal	Annals of Oncology
Volume	33
Issue number	Suppl. 7
Pages (from-to)	S723
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2022.07.548
Publication status	Published - Sept 2022
Event	ESMO Congress 2022 - Paris Expo Porte de Versailles, Paris, France Duration: 9 Sept 2022 → 13 Sept 2022 https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Conference

Conference	ESMO Congress 2022
Location	Paris Expo Porte de Versailles
Country/Territory	France
City	Paris
Period	09/09/2022 → 13/09/2022
Internet address	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Bibliographical note

Abstract No. 410P

Access to Document

10.1016/j.annonc.2022.07.548

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Liposits, G., Ryg, J., Skuladottir, H., Winther, S. B., Möller, S., Hofsli, E., Shah, C.-H., Oestergaard, L. P., Berglund, A., Qvortrup, C., Osterlund, P. J., Glimelius, B., Sorbye, H., & Pfeiffer, P. (2022). Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study. Annals of Oncology, 33(Suppl. 7), S723. Article 410P . https://doi.org/10.1016/j.annonc.2022.07.548

@article{73140fdf592e4806b43d143629395031,

title = "Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study",

author = "G. Liposits and J. Ryg and H. Skuladottir and Winther, {S. B.} and S. M{\"o}ller and E. Hofsli and C-H. Shah and Oestergaard, {L. Poulsen} and A. Berglund and C. Qvortrup and Osterlund, {P. J.} and B. Glimelius and H. Sorbye and P. Pfeiffer",

note = "Abstract No. 410P ; ESMO Congress 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.548",

language = "English",

volume = "33",

pages = "S723",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 7",

url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022",

}

Liposits, G, Ryg, J, Skuladottir, H, Winther, SB, Möller, S, Hofsli, E, Shah, C-H, Oestergaard, LP, Berglund, A, Qvortrup, C, Osterlund, PJ, Glimelius, B, Sorbye, H & Pfeiffer, P 2022, 'Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study', Annals of Oncology, vol. 33, no. Suppl. 7, 410P , pp. S723. https://doi.org/10.1016/j.annonc.2022.07.548

Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study. / Liposits, G.; Ryg, J.; Skuladottir, H. et al.
In: Annals of Oncology, Vol. 33, No. Suppl. 7, 410P , 09.2022, p. S723.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

AU - Liposits, G.

AU - Ryg, J.

AU - Skuladottir, H.

AU - Winther, S. B.

AU - Möller, S.

AU - Hofsli, E.

AU - Shah, C-H.

AU - Oestergaard, L. Poulsen

AU - Berglund, A.

AU - Qvortrup, C.

AU - Osterlund, P. J.

AU - Glimelius, B.

AU - Sorbye, H.

AU - Pfeiffer, P.

N1 - Abstract No. 410P

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.548

DO - 10.1016/j.annonc.2022.07.548

M3 - Conference abstract in journal

SN - 0923-7534

VL - 33

SP - S723

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 7

M1 - 410P

T2 - ESMO Congress 2022

Y2 - 9 September 2022 through 13 September 2022

ER -

Liposits G, Ryg J, Skuladottir H, Winther SB, Möller S, Hofsli E et al. Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study. Annals of Oncology. 2022 Sept;33(Suppl. 7):S723. 410P . doi: 10.1016/j.annonc.2022.07.548